Travaux scientifiques

Doç. Dr. Mesut Göçer

27 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil
  1. Comparative efficacy and safety of G-CSF alone versus G-CSF combined with different doses of cyclophosphamide for peripheral blood stem cell mobilization in patients with multiple myeloma

    Transfusion and Apheresis Science, 2026

    DOI 10.1016/j.transci.2026.104490 PMID 42431019 Source : ORCID

  2. Effects of Splenectomy on Natural Killer Cell Levels in β‐Thalassemia Major Patients

    Journal of Clinical Laboratory Analysis, 2024

    DOI 10.1002/jcla.25046 PMID 38814004 3 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  3. The Relationship Between Ghrelin and Iron Metabolism In Beta Thalassemia Major Patients

    Archives of Medical Science, 2024

    DOI 10.5114/aoms/184702 PMID 41078927 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  4. The Relationshıp Between Ghrelin And Iron Metabolism In Beta Thassemia Major Patients

    Research Square, 2023

    DOI 10.21203/rs.3.rs-3180782/v1 Texte intégral en libre accèsSource : OpenAlex

  5. The Relationship Between Ghrelin and Iron Metabolism in Beta Thassemia Major Patients

    Research Square, 2023

    DOI 10.21203/rs.3.rs-3163185/v1 Texte intégral en libre accèsSource : OpenAlex

  6. Turkey Real-Life Data: Demographic Features, Treatment Results and Effects of Comorbidities in Chronic Myeloid Leukemia

    International Journal of Hematologic Oncology, 2022

    DOI 10.2217/ijh-2021-0008 PMID 36101779 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  7. IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY

    Mediterranean Journal of Hematology and Infectious Diseases, 2022

    DOI 10.4084/mjhid.2022.074 PMID 36425152 6 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  8. Prognostic significance of hematogone presence after autologous stem cell transplantation in patients with multiple myeloma

    Cytometry Part B: Clinical Cytometry, 2021

    DOI 10.1002/cyto.b.22003 PMID 33905180 1 citation (Europe PMC) Texte intégral en libre accèsSource : ORCID

  9. Effect of prophylactic leukapheresis on early mortality and overall survival in acute leukemia patients with hyperleukocytosis

    Therapeutic Apheresis and Dialysis, 2021

    DOI 10.1111/1744-9987.13645 PMID 33686785 7 citations (Europe PMC) Source : ORCID

  10. Is absence of CD56 a predictive factor for peripheral blood stem cell mobilization failure in patients with multiple myeloma?

    Journal of Clinical Apheresis, 2021

    DOI 10.1002/jca.21864 PMID 33333593 2 citations (Europe PMC) Source : ORCID

  11. Evaluation of clinical features and treatment responses in patients with chronic myeloid leukemia: A single center experience

    Harran Üniversitesi Tıp Fakültesi Dergisi, 2021

    DOI 10.35440/hutfd.853074 2 citations (OpenAlex) Texte intégral en libre accèsSource : ORCID

  12. Comparison of Bone Marrow Involvement with Bone Marrow Biopsy and PET–CT and Evaluation of Any Effects on Survival in Patients Diagnosed with Hodgkin and Non-Hodgkin Lymphoma

    Indian Journal of Hematology and Blood Transfusion, 2021

    DOI 10.1007/s12288-020-01284-x PMID 33707835 4 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  13. Prognostic significance of neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, platelet/neutrophil ratio, and mean platelet volume in patients diagnosed with Hodgkin and Non-Hodgkin Lymphoma

    Turkish Journal of Clinics and Laboratory, 2020

    DOI 10.18663/tjcl.767943 Texte intégral en libre accèsSource : ORCID

  14. Effect of the ABO blood groups on the development, clinical features and survival of multiple myeloma.

    Memo, 2020

    DOI 10.1007/s12254-020-00669-y PMID 33362882 2 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  15. Safety and efficacy analysis of ibrutinib in 32 patients with CLL and various B-cell lymphomas: real-world data from a single-center study in Turkey

    Blood research, 2020

    DOI 10.5045/br.2020.2020158 PMID 33303706 6 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  16. Clinical significiance of increased FDG uptake in the Waldeyer’s ring and the Nasopharynx region identified in PET-CT in the post-chemotherapy follow-up in patients with lymphoma: When should we perform biopsy?

    Clinical Lymphoma Myeloma and Leukemia, 2020

    DOI 10.1016/j.clml.2020.08.004 PMID 32917575 4 citations (Europe PMC) Source : ORCID

  17. Thrombotic Thrombocytopenic Purpura Cases and Consumption of Large Quantities of Energy Drink: Related or Coincidence?

    Acta Haematologica, 2020

    DOI 10.1159/000500665 PMID 31167181 Source : ORCID

  18. Talasemide Yaşam Kalitesi ve Artırmaya Yönelik Rehberler

    2020

    Source : OpenAlex

  19. Myelofibrozis hastalarında Ruxolitinib kullanımı: tek merkez deneyimi ve JAK-2 allel yükü ile Ruxolitinib yanıtı arasındaki ilişki

    Pamukkale Medical Journal, 2020

    DOI 10.31362/patd.770631 Texte intégral en libre accèsSource : OpenAlex

  20. PB1933 CLINICAL FEATURES AND TREATMENT OUTCOMES OF CHRONIC PHASE‐CHRONIC MYELOID LEUKEMIA PATIENTS IN TURKEY: REAL‐WORLD DATA

    HemaSphere, 2019

    DOI 10.1097/01.hs9.0000566228.27858.e5 Texte intégral en libre accèsSource : OpenAlex

  21. Survival analysis of patients with Sjögren’s syndrome in Turkey: a tertiary hospital-based study

    Clinical Rheumatology, 2019

    DOI 10.1007/s10067-019-04744-6 PMID 31555987 28 citations (Europe PMC) Source : ORCID

  22. THREE CHRONIC MYELOID LEUKEMIA CASES THAT PRESENTED LIKE ESSENTIAL THROMBOCYTHEMIA

    HemaSphere, 2019

    DOI 10.1097/01.hs9.0000566340.36375.a0 2 citations (OpenAlex) Texte intégral en libre accèsSource : ORCID

  23. Kaposi sarcoma following autoimmune hemolytic anemia in a patient with chronic lymphocytic leukemia

    memo - Magazine of European Medical Oncology, 2019

    DOI 10.1007/s12254-018-0445-6 2 citations (OpenAlex) Source : ORCID

  24. False elevations of vitamin B12 levels due to assay errors in a patient with pernicious anemia

    Blood Research, 2019

    DOI 10.5045/br.2019.54.2.149 PMID 31309095 7 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

  25. DEMOGRAPHIC AND CLINICAL FEATURES OF PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME IN ANTALYA

    DergiPark (Istanbul University), 2019

    Texte intégral en libre accèsSource : OpenAlex

  26. THU0243 Can the increase of lobules / foci ratio be histopathological evidence of primary sjÖgren's syndrome

    Annals of the Rheumatic Diseases, 2017

    DOI 10.1136/annrheumdis-2017-eular.4014 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  27. FRI0349 A Survival Analysis of Patients with Primary Sjögren's Syndrome

    Annals of the Rheumatic Diseases, 2016

    DOI 10.1136/annrheumdis-2016-eular.3742 Source : ORCID